Placebo-controlled pharmacological trials in child and adolescents with bipolar disorder manic episode (BPD-ME): Systematic review, meta-analysis and a meta-regression on placebo response (eng)
Objective: Randomized placebo controlled trials (RCT) are very important for testing efficacy and safety of a medical treatment. There is no too much RCT`s in childhood bipolar disorder manic episode. In these trials, high placebo response poses a problem for the definition of real drug responses in...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
ANP Publishing
2020-06-01
|
| Series: | Klinik Psikiyatri Dergisi |
| Subjects: | |
| Online Access: | https://www.journalagent.com/z4/download_fulltext.asp?pdir=kpd&un=KPD-45822 |
| _version_ | 1797914427744321536 |
|---|---|
| author | Remzi Oğulcan Çıray Pelin Hançer Mustafa Tunçtürk Neslihan İnal Emiroğlu |
| author_facet | Remzi Oğulcan Çıray Pelin Hançer Mustafa Tunçtürk Neslihan İnal Emiroğlu |
| author_sort | Remzi Oğulcan Çıray |
| collection | DOAJ |
| description | Objective: Randomized placebo controlled trials (RCT) are very important for testing efficacy and safety of a medical treatment. There is no too much RCT`s in childhood bipolar disorder manic episode. In these trials, high placebo response poses a problem for the definition of real drug responses in practice. Therefore, analysis of predictors of drug and placebo response are important for conducting more reliable RCT`s in the future.
Method: Comprehensive search conducted in PubMed, ClinicalTrials.gov, Cochrane Central Register of Controlled Trials (CENTRAL) and some other electronic databases. Studies including participants with Bipolar Disorder manic episode and associated symptoms (e.g ADHD, irritability) included. There was no restriction in terms of sex, ethnicity or initial severity. Participants over age 18 were excluded. Random effect size model was used for calculate effect sizes for placebo and drugs.
Results: A total of 1974 participants and 11 studies were included in the meta-analysis. Risperidone was highest effect size among drug arms. Number of the sites and number of the participants were associated with higher placebo response in meta-regression. We did not find any variable had an impact on drug response. There was no any publication bias in this meta-analysis.
Conclusion: We found similar results as adult studies. Modifying number of the sites or ramdomized sample size may limit placebo response and could improve the efficacy of RCT`s and enhance drug-placebo contrasts. |
| first_indexed | 2024-04-10T12:27:32Z |
| format | Article |
| id | doaj.art-5f6c04c8699e4efbb6342f9508acc2c0 |
| institution | Directory Open Access Journal |
| issn | 1302-0099 |
| language | English |
| last_indexed | 2024-04-10T12:27:32Z |
| publishDate | 2020-06-01 |
| publisher | ANP Publishing |
| record_format | Article |
| series | Klinik Psikiyatri Dergisi |
| spelling | doaj.art-5f6c04c8699e4efbb6342f9508acc2c02023-02-15T16:15:07ZengANP PublishingKlinik Psikiyatri Dergisi1302-00992020-06-0123337538510.5505/kpd.2020.45822KPD-45822Placebo-controlled pharmacological trials in child and adolescents with bipolar disorder manic episode (BPD-ME): Systematic review, meta-analysis and a meta-regression on placebo response (eng)Remzi Oğulcan Çıray0Pelin Hançer1Mustafa Tunçtürk2Neslihan İnal Emiroğlu3Dokuz Eylul University Medical School, Child Psychiatry Department, IzmirDokuz Eylul University Nursing School, Psychiatry Nursing Department, IzmirBakirkoy Mazhar Osman Psychiatric Hospital, Psychiatry Department, IstanbulDokuz Eylul University Medical School, Child Psychiatry Department, IzmirObjective: Randomized placebo controlled trials (RCT) are very important for testing efficacy and safety of a medical treatment. There is no too much RCT`s in childhood bipolar disorder manic episode. In these trials, high placebo response poses a problem for the definition of real drug responses in practice. Therefore, analysis of predictors of drug and placebo response are important for conducting more reliable RCT`s in the future. Method: Comprehensive search conducted in PubMed, ClinicalTrials.gov, Cochrane Central Register of Controlled Trials (CENTRAL) and some other electronic databases. Studies including participants with Bipolar Disorder manic episode and associated symptoms (e.g ADHD, irritability) included. There was no restriction in terms of sex, ethnicity or initial severity. Participants over age 18 were excluded. Random effect size model was used for calculate effect sizes for placebo and drugs. Results: A total of 1974 participants and 11 studies were included in the meta-analysis. Risperidone was highest effect size among drug arms. Number of the sites and number of the participants were associated with higher placebo response in meta-regression. We did not find any variable had an impact on drug response. There was no any publication bias in this meta-analysis. Conclusion: We found similar results as adult studies. Modifying number of the sites or ramdomized sample size may limit placebo response and could improve the efficacy of RCT`s and enhance drug-placebo contrasts.https://www.journalagent.com/z4/download_fulltext.asp?pdir=kpd&un=KPD-45822pediatric bipolar disorderplacebo responsemeta-analysischild and adolescent |
| spellingShingle | Remzi Oğulcan Çıray Pelin Hançer Mustafa Tunçtürk Neslihan İnal Emiroğlu Placebo-controlled pharmacological trials in child and adolescents with bipolar disorder manic episode (BPD-ME): Systematic review, meta-analysis and a meta-regression on placebo response (eng) Klinik Psikiyatri Dergisi pediatric bipolar disorder placebo response meta-analysis child and adolescent |
| title | Placebo-controlled pharmacological trials in child and adolescents with bipolar disorder manic episode (BPD-ME): Systematic review, meta-analysis and a meta-regression on placebo response (eng) |
| title_full | Placebo-controlled pharmacological trials in child and adolescents with bipolar disorder manic episode (BPD-ME): Systematic review, meta-analysis and a meta-regression on placebo response (eng) |
| title_fullStr | Placebo-controlled pharmacological trials in child and adolescents with bipolar disorder manic episode (BPD-ME): Systematic review, meta-analysis and a meta-regression on placebo response (eng) |
| title_full_unstemmed | Placebo-controlled pharmacological trials in child and adolescents with bipolar disorder manic episode (BPD-ME): Systematic review, meta-analysis and a meta-regression on placebo response (eng) |
| title_short | Placebo-controlled pharmacological trials in child and adolescents with bipolar disorder manic episode (BPD-ME): Systematic review, meta-analysis and a meta-regression on placebo response (eng) |
| title_sort | placebo controlled pharmacological trials in child and adolescents with bipolar disorder manic episode bpd me systematic review meta analysis and a meta regression on placebo response eng |
| topic | pediatric bipolar disorder placebo response meta-analysis child and adolescent |
| url | https://www.journalagent.com/z4/download_fulltext.asp?pdir=kpd&un=KPD-45822 |
| work_keys_str_mv | AT remziogulcancıray placebocontrolledpharmacologicaltrialsinchildandadolescentswithbipolardisordermanicepisodebpdmesystematicreviewmetaanalysisandametaregressiononplaceboresponseeng AT pelinhancer placebocontrolledpharmacologicaltrialsinchildandadolescentswithbipolardisordermanicepisodebpdmesystematicreviewmetaanalysisandametaregressiononplaceboresponseeng AT mustafatuncturk placebocontrolledpharmacologicaltrialsinchildandadolescentswithbipolardisordermanicepisodebpdmesystematicreviewmetaanalysisandametaregressiononplaceboresponseeng AT neslihaninalemiroglu placebocontrolledpharmacologicaltrialsinchildandadolescentswithbipolardisordermanicepisodebpdmesystematicreviewmetaanalysisandametaregressiononplaceboresponseeng |